Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DNAVAC 001: A Phase 1 Open-labelled Trial to Optimise DNA Vaccination for Antibody Induction

NCT03663998 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT03663998
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03663998 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DNAVAC 001: A Phase 1 Open-labelled Trial to Optimise DNA Vaccination for Antibody Induction
Lead sponsor
Imperial College London
Phase
Phase 1
Overall status
Completed
Start date
August 15, 2015
Completion date
April 10, 2018
Enrollment
36 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-1-infection